Blood salvage and allogenic transfusion needs in revision hip arthroplasty

Kevin L. Garvin, Connie A. Feschuk, Todd D. Sekundiak, Elizabeth R. Lyden

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Blood transfusions frequently are required after revision total hip arthroplasty, and although autologous and allogenic transfusions are effective in replacing blood loss, they are not without risks. To reduce the dependency on these types of transfusions, intraoperative blood collection and return by autotransfusion replacement systems are being used as an alternative or conjunctive therapy. We retrospectively reviewed 147 hip revision surgeries to determine if autotransfusion replacement systems return from the Cell Saver® or the OrthoPat® decreased the need for allogenic blood. We also questioned if components revised and preoperative hematocrit were risk factors for allogenic transfusion. The two blood salvage systems were compared for blood loss, autotransfusion replacement systems collection and return, allogenic use, and the implants replaced. Both systems were found to replace at least 42% of blood lost during surgery, averaging a return of 370 mL. Allogenic blood transfused was reduced by 31% with the use of an autotransfusion replacement systems machine. Risk factors found to be associated with the need for allogenic transfusions are femoral component revision or femoral and acetabular revision, preoperative hematocrit less than 45%, and autotransfusion replacement systems return greater than 300 mL.

Original languageEnglish
Pages (from-to)205-209
Number of pages5
JournalClinical Orthopaedics and Related Research
Issue number441
DOIs
StatePublished - Dec 2005
Externally publishedYes

Fingerprint

Autologous Blood Transfusions
Arthroplasty
Hip
Thigh
Hematocrit
Blood Transfusion
Reoperation

All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Blood salvage and allogenic transfusion needs in revision hip arthroplasty. / Garvin, Kevin L.; Feschuk, Connie A.; Sekundiak, Todd D.; Lyden, Elizabeth R.

In: Clinical Orthopaedics and Related Research, No. 441, 12.2005, p. 205-209.

Research output: Contribution to journalArticle

Garvin, Kevin L. ; Feschuk, Connie A. ; Sekundiak, Todd D. ; Lyden, Elizabeth R. / Blood salvage and allogenic transfusion needs in revision hip arthroplasty. In: Clinical Orthopaedics and Related Research. 2005 ; No. 441. pp. 205-209.
@article{e8993714fdfb4e34834bbd7ca6d6d34d,
title = "Blood salvage and allogenic transfusion needs in revision hip arthroplasty",
abstract = "Blood transfusions frequently are required after revision total hip arthroplasty, and although autologous and allogenic transfusions are effective in replacing blood loss, they are not without risks. To reduce the dependency on these types of transfusions, intraoperative blood collection and return by autotransfusion replacement systems are being used as an alternative or conjunctive therapy. We retrospectively reviewed 147 hip revision surgeries to determine if autotransfusion replacement systems return from the Cell Saver{\circledR} or the OrthoPat{\circledR} decreased the need for allogenic blood. We also questioned if components revised and preoperative hematocrit were risk factors for allogenic transfusion. The two blood salvage systems were compared for blood loss, autotransfusion replacement systems collection and return, allogenic use, and the implants replaced. Both systems were found to replace at least 42{\%} of blood lost during surgery, averaging a return of 370 mL. Allogenic blood transfused was reduced by 31{\%} with the use of an autotransfusion replacement systems machine. Risk factors found to be associated with the need for allogenic transfusions are femoral component revision or femoral and acetabular revision, preoperative hematocrit less than 45{\%}, and autotransfusion replacement systems return greater than 300 mL.",
author = "Garvin, {Kevin L.} and Feschuk, {Connie A.} and Sekundiak, {Todd D.} and Lyden, {Elizabeth R.}",
year = "2005",
month = "12",
doi = "10.1097/01.blo.0000192033.50316.bf",
language = "English",
pages = "205--209",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "441",

}

TY - JOUR

T1 - Blood salvage and allogenic transfusion needs in revision hip arthroplasty

AU - Garvin, Kevin L.

AU - Feschuk, Connie A.

AU - Sekundiak, Todd D.

AU - Lyden, Elizabeth R.

PY - 2005/12

Y1 - 2005/12

N2 - Blood transfusions frequently are required after revision total hip arthroplasty, and although autologous and allogenic transfusions are effective in replacing blood loss, they are not without risks. To reduce the dependency on these types of transfusions, intraoperative blood collection and return by autotransfusion replacement systems are being used as an alternative or conjunctive therapy. We retrospectively reviewed 147 hip revision surgeries to determine if autotransfusion replacement systems return from the Cell Saver® or the OrthoPat® decreased the need for allogenic blood. We also questioned if components revised and preoperative hematocrit were risk factors for allogenic transfusion. The two blood salvage systems were compared for blood loss, autotransfusion replacement systems collection and return, allogenic use, and the implants replaced. Both systems were found to replace at least 42% of blood lost during surgery, averaging a return of 370 mL. Allogenic blood transfused was reduced by 31% with the use of an autotransfusion replacement systems machine. Risk factors found to be associated with the need for allogenic transfusions are femoral component revision or femoral and acetabular revision, preoperative hematocrit less than 45%, and autotransfusion replacement systems return greater than 300 mL.

AB - Blood transfusions frequently are required after revision total hip arthroplasty, and although autologous and allogenic transfusions are effective in replacing blood loss, they are not without risks. To reduce the dependency on these types of transfusions, intraoperative blood collection and return by autotransfusion replacement systems are being used as an alternative or conjunctive therapy. We retrospectively reviewed 147 hip revision surgeries to determine if autotransfusion replacement systems return from the Cell Saver® or the OrthoPat® decreased the need for allogenic blood. We also questioned if components revised and preoperative hematocrit were risk factors for allogenic transfusion. The two blood salvage systems were compared for blood loss, autotransfusion replacement systems collection and return, allogenic use, and the implants replaced. Both systems were found to replace at least 42% of blood lost during surgery, averaging a return of 370 mL. Allogenic blood transfused was reduced by 31% with the use of an autotransfusion replacement systems machine. Risk factors found to be associated with the need for allogenic transfusions are femoral component revision or femoral and acetabular revision, preoperative hematocrit less than 45%, and autotransfusion replacement systems return greater than 300 mL.

UR - http://www.scopus.com/inward/record.url?scp=33644798144&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644798144&partnerID=8YFLogxK

U2 - 10.1097/01.blo.0000192033.50316.bf

DO - 10.1097/01.blo.0000192033.50316.bf

M3 - Article

SP - 205

EP - 209

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 441

ER -